| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.67 | 0.009 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |